Gene Query: VWF

Dataset Description Geneva Score
Rorc disruption in human FG pancreatic cancer cells 90.76
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 85.01
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 83.03
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 74.74
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 74.22
Investigation about fibroblasts of different origins in culture 62.87
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 57.61
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 51.75
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 45.36
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 44.2
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 41.91
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 39.9
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 39.7
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 39.7
Transcriptome analysis of virus infected tissues 39.53
Gene expression profiling of papillary thyroid cancer from central and invasive regions 38.86
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 37.85
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 36.99
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 36.85
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 36.77
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 34.34
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 34.21
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 34.09
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 33.92
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 33.71
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 33.36
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 32.84
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 32.84
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 32.65
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 32.61
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 30.77
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 29.17
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 26.66
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 26.66
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 26.61
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 26.17
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 26.01
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 25.71
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 25.34
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 24.47
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 24.0
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 23.93
RNA sequencing with KSHV infection and enrichment for circular RNAs 23.82
An acquired vulnerability of drug resistant melanoma with therapeutic potential 23.71
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 23.71
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 23.08
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 23.08
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 22.81
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 22.5
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 22.5
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 22.08
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 22.06
Gene Expression Profiling of WT and KDM3A Knocked out Cell 21.69
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 21.69
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 20.81
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 20.74
Human ovarian granulosa cell transcriptome 20.54
Single cell transcriptome of peritoneal cells 19.71
Global epigenomic reconfiguration during mammalian brain development 19.47
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 18.9
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 18.85
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 18.64
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 18.64
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 17.56
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 17.05
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 16.78
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 16.38
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 16.37
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 16.36
Neonatal and adult human testis defined at the single-cell level 16.35
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 16.22
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 16.22
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 16.16
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 15.89
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 15.89
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 15.78
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 15.58
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 15.56
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 15.27
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 14.8
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 14.79
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 14.7
Noncoding regions are the main source of targetable tumor-specific antigens 14.58
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 14.14
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 13.91
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 13.81
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 13.64
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 13.62
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 13.55
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 13.48
Transcriptional profiling of microglia; current state of the art and future perspectives 13.23
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 13.19
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 13.19
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 13.0
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 12.31
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 12.14
Identification of Atrial Fibrillation associated genes and functional non-coding variants 12.01
RNA Sequencing of three pairs of gastric cancer 11.9
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 11.78
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 11.65
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 11.62
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 11.55
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 11.46
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 11.46
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 11.46
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 11.32
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 11.32
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 11.21
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 11.18
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 11.18
RNA-sequencing of formalin fixed human primary melanoma tissue 11.08
Genome-wide identification of cancer-specific alternative splicing in circRNA 11.06
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 11.01
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 10.78
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 10.73
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 10.67
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 10.58
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 10.54
Repurposing of promoters and enhancers during mammalian evolution 10.46
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 10.4
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 10.36
Dynamic reorganization of nuclear architecture during human cardiogenesis 10.25
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 10.25
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 10.24
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 10.12
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 9.89
Epigenomic landscape during organ formation in human early embryos 9.88
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 9.75
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 9.75
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 9.61
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 9.58
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 9.57
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 9.45
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 9.45
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 9.41
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 9.41
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 9.34
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 9.26
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 9.26
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 9.13
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 8.88
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 8.81
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 8.72
Patient-derived xenograft platform for metastatic melanoma 8.63
Transcriptome analyses of human pancreatic islets and pseudoislets 8.59
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 8.52
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 8.48
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 8.47
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 8.19
Common inflammatory pathways between NEC and Crohn's disease 8.13
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 8.09
RNA-sequencing of human tendon after injury 8.06
DIGIT regulates endoderm differentiation of human embryonic stem cells 8.06
The role of CFTR in islet function 7.98
Differentially expressed vascular development genes for iPSC-ECs from CDI 7.91
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.81
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.81
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 7.7
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 7.66
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 7.65
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 7.63
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 7.63
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 7.63
circRNA-sequencing 7.57
Fibroblasts in cholesteatoma activate osteoclasts. 7.47
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 7.42
RNA-Seq analysis of human colorectal cancer with liver metastasis 7.38
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 7.33
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 7.24
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 7.24
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 7.18
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 7.15
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 7.12
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 7.12
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 7.05
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 6.99
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 6.83
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 6.71
The gene expression profiles of gallbladder cancer 6.69
RNA-seq in endometrial stromal tumors 6.52
The conserved transcriptional landscapes in human spermatogenesis 6.51
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 6.44
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 6.43
Molecular analysis of renal cell carcinoma with unclassfied histology 6.43
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 6.43
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 6.42
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 6.42
Evaluating pre-clinical models for studying NASH driven HCC. 6.31
RNA Seq of HMVEC under hypoxia 6.24
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 6.24
The expression profiles of GBC liver metastasis 6.13
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 6.03
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 5.96
Non-coding regions are the main source of tumor-specific antigens [human] 5.95
Non-coding regions are the main source of tumor-specific antigens 5.95
circRNA profile in hypopharyngeal cancer 5.93
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 5.92
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 5.92
RNA-seq melanoma 5.89
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 5.86
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 5.84
miR-93 Targets in Human Endothelial Cells 5.75
Widespread regulated alternative splicing of single codons accelerates proteome evolution 5.72
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 5.59
CUREfast: Accelerating research with families 5.59
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 5.56
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 5.53
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 5.53
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 5.52
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 5.52
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 5.48
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 5.45
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 5.36
RNAseq analysis of ruxolitinib treated breast cancers 5.27
Aortic Valve Tissue: Stenosis vs. Sclerosis 5.26
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 5.26
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 5.16
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 5.13
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 5.1
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 5.1
The landscape of alternative splicing in aggressive prostate cancers 5.05
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 5.04
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 5.03
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 5.03
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 4.99
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 4.99
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 4.99
Gene expression analysis of human liver progenitor-like cells in culture 4.97
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 4.96
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.95
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.94
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 4.94
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 4.92
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 4.92
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 4.9
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 4.85
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 4.85
Illumina HiSeq Sequencing on Breast cancer PDX samples 4.83
The age and genomic integrity of neurons after cortical stroke in humans 4.81
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 4.81
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 4.7
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 4.64
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 4.63
Gene expression profiling in metabolically heterogeneous human lung tumors 4.63
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 4.63
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 4.63
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 4.61
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 4.6
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 4.57
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 4.57
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 4.55
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.53
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.53
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 4.52
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 4.46
Human T-cell lymphoblastic lymphoma samples and control thymuses 4.38
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 4.38
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 4.38
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 4.33
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 4.31
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 4.29
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 4.16
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 4.16
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 4.13
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 4.12
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 4.01
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 4.01
Generation of trichogenic adipose-derived stem cells by expression of three factors 4.01
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 3.94
RNA-seq of stable and unstable section of human atherosclerotic plaques 3.93
Exploring the RNA landscape of endothelial exosomes 3.82
The DNA methylation landscape of human melanoma [RNA-Seq] 3.8
The DNA methylation landscape of human melanoma 3.8
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 3.74
Single-cell analysis of adult human ovary using 10X genomics 3.73
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 3.71
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 3.69
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 3.51
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 3.45
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 3.43
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 3.42
Leucegene: ALL sequencing 3.41
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 3.35
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 3.35
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 3.35
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 3.33
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.31
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 3.27
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 3.26
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 3.21
The transcriptome of Kawasaki Disease arteritis 3.21
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.19
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.19
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 3.17
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 3.17
Persistence of stem cell metabolism in cancers as a failure of differentiation 3.15
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 3.13
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 3.11
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 3.06
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 3.06
RNA-sequencing 3.02
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 2.98
Modeling Human Cancer-induced Cachexia (Human) 2.98
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 2.97
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.97
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.96
RNA-seq of CD33 KO and control HSPCs 2.92
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 2.87
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 2.84
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.82
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 2.79
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 2.78
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.74
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 2.74
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.74
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.72
Transcriptome Profiling of Human Primary Monocytes 2.72
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 2.7
Characterization of the Merkel cell carcinoma miRNome 2.61
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 2.61
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.61
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.61
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.6
RNA-seq analysis of RALD iPSCs after in vitro differentiation 2.6
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.55
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.54
RNA sequencing of T-ALL (COG study) 2.52
Analyses of T-ALL (COG study) 2.52
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.52
Loss of endometrial plasticity in recurrent pregnancy loss 2.52
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 2.51
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 2.5
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 2.41
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 2.4
Hepatic transcriptome of pediatric hepatoblastoma. 2.39
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 2.31
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 2.25
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 2.25
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 2.23
RNA-Seq of the corpus callosum from 12 individuals 2.22
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 2.1
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.08
Transcriptome analysis reveals differential splicing events in IPF lung tissue 2.07
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.05
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 2.01
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 2.01
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 2.0
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.99
Universal alternative splicing of noncoding exons 1.93
The Glioma-Infiltrating T Cell Receptor Repertoire 1.89
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.82
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 1.81
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.8
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.8
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.77
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.77
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 1.77
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 1.67
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.67
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.66
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.66
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 1.64
mRNA-sequencing of breast cancer subtypes and normal tissue 1.62
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.6
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.58
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.57
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.56
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 1.53
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 1.52
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 1.51
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 1.5
Transcriptomes in healthy and CHB fetal hearts 1.5
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 1.48
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 1.45
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 1.44
Tpl-2 small molecule project 1.4
Tpl-2 and MEK small molecule inhibitors 1.4
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.39
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.38
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.37
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.35
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.34
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 1.32
Endometrial transcriptome and PGR cistrome in cycling fertile women 1.31
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 1.31
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 1.31
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.29
Gene expression analysis of human hepatocellular cancers 1.27
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.26
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.22
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 1.19
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.19
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.19
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 1.16
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.15
RNAseq in Alzheimer's Disease patients 1.09
Dermal endothelial cells of type 2 diabetic patients 1.08
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.07
Human islets of varying quality: the good, the (not so) bad and the ugly 1.07
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 1.06
STX4 Over-Expression in Human islets 1.05
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 1.05
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.04
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.0
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 0.96
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 0.96
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.96
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 0.94
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.91
Impact on erythroid progenitor type on erythroid differntiation 0.89
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.89
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.89
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.84
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.83
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.83
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.82
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.82
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 0.81
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.79
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.74
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.73
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.72
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.71
A practical evaluation of alignment algorithms for RNA variant calling analysis 0.7
RNA-seq of naive and primed ES cells 0.7
RNA-sequencing of human liver tissue 0.7
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.7
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.69
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 0.65
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.64
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.62
Deep RNA sequencing of the human placental transcriptome 0.61
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.61
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.59
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.58
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.58
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.58
Gene expression profile difference among renal location in a stone former 0.57
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.56
Gene expression of collecting duct carcinoma of the kidney 0.56
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.52
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 0.51
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.5
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.5
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.5
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.48
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.47
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.47
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 0.45
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.43
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.42
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 0.42
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.4
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.39
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.38
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 0.38
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.37
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.36
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.35
Dilated cardiomyopathy vs Myocarditis 0.35
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.35
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 0.34
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.33
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.33
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.33
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.31
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.29
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.29
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.28
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.26
ML29755 RNA-seq data 0.25
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.24
Single-Cell Genotyping of Transcriptomes 0.24
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.22
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 0.22
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.19
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.18
Hepatosplenic T cell lymphoma 0.18
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.17
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.16
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.15
RNA-Seq and expression data from human adipose tissue 0.15
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.11
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.1
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.1
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.1
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 0.09
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.08
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.08
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.08
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.06
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.04
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.03
Identification of expressed and conserved human non-coding RNAs 0.02
Transcriptomic analysis of frontal fibrosing alopecia 0.02
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.02
Gene expression profile of human placenta from T. Cruzi infected mothers 0.01
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 0.01
RNA-seq analysis of gene expression patterns during hESC neural differentiation 0.01
hESC neural differentiation 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation